These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7494604)

  • 1. Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins.
    Ellison DW; Steart PV; Gatter KC; Weller RO
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):352-61. PubMed ID: 7494604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
    Sarkar C; Karak AK; Nath N; Sharma MC; Mahapatra AK; Chattopadhyay P; Sinha S
    J Neurooncol; 2005 Jun; 73(2):93-100. PubMed ID: 15981097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.
    Ellison DW; Steart PV; Bateman AC; Pickering RM; Palmer JD; Weller RO
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):413-9. PubMed ID: 7561922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of cyclin A in astrocytic tumours.
    Chakrabarty A; Bridges LR
    Neuropathol Appl Neurobiol; 1998 Jun; 24(3):239-45. PubMed ID: 9717190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased endothelial expression of transglutaminase in glioblastomas.
    Hilton DA; Love S; Barber R
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):507-11. PubMed ID: 9460717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
    Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
    J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of apoptotic pathways and c.Jun/JNK expression in malignant gliomas.
    Schiffer D; Ferracini R; Cavalla P
    Anticancer Res; 2001; 21(4A):2531-5. PubMed ID: 11724318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in astrocytic neoplasms.
    Carroll RS; Zhang J; Chauncey BW; Chantziara K; Frosch MP; Black PM
    Acta Neurochir (Wien); 1997; 139(9):845-50. PubMed ID: 9351989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of immunohistochemistry in predicting behavior of astrocytic tumors.
    Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S
    Asian Pac J Cancer Prev; 2010; 11(4):1079-84. PubMed ID: 21133628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
    Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
    Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
    Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
    Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
    Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
    Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
    Ioffe OB; Papadimitriou JC; Drachenberg CB
    Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 protein and epidermal growth factor receptor expression in human astrocytomas.
    Kordek R; Biernat W; Alwasiak J; Maculewicz R; Yanagihara R; Liberski PP
    J Neurooncol; 1995 Oct; 26(1):11-6. PubMed ID: 8583240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions.
    Khalid H; Tsutsumi K; Yamashita H; Kishikawa M; Yasunaga A; Shibata S
    Cell Mol Neurobiol; 1995 Apr; 15(2):257-68. PubMed ID: 8590455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors.
    Hara A; Hirose Y; Yoshimi N; Tanaka T; Mori H
    Neurol Res; 1997 Dec; 19(6):623-8. PubMed ID: 9427964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype.
    De Angelis PM; Stokke T; Thorstensen L; Lothe RA; Clausen OP
    Mol Pathol; 1998 Oct; 51(5):254-61. PubMed ID: 10193519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
    Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C
    Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 in astrocytic tumours: an immunohistochemical study.
    Chakrabarty A; Bridges LR; Gray S
    Neuropathol Appl Neurobiol; 1996 Aug; 22(4):311-6. PubMed ID: 8875465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.